These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

917 related articles for article (PubMed ID: 17517403)

  • 1. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
    Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
    Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation.
    Huang JY; Tulandi T; Holzer H; Tan SL; Chian RC
    Fertil Steril; 2008 Mar; 89(3):567-72. PubMed ID: 17543957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live birth after vitrification of in vitro matured human oocytes.
    Chian RC; Gilbert L; Huang JY; Demirtas E; Holzer H; Benjamin A; Buckett WM; Tulandi T; Tan SL
    Fertil Steril; 2009 Feb; 91(2):372-6. PubMed ID: 18514195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification.
    Sánchez-Serrano M; Crespo J; Mirabet V; Cobo AC; Escribá MJ; Simón C; Pellicer A
    Fertil Steril; 2010 Jan; 93(1):268.e11-3. PubMed ID: 19880105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrieval of immature oocytes after chemotherapy for Hodgkin's disease and prolonged ovarian down-regulation with gonadotropin-releasing hormone agonist.
    Azem F; Hasson J; Cohen T; Shwartz T; Mey-Raz N; Almog B; Amit A; Ben-Yosef D
    Fertil Steril; 2009 Aug; 92(2):828.e1-2. PubMed ID: 19524895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful delivery after the transfer of embryos obtained from a cohort of incompletely in vivo matured oocytes at retrieval time.
    Fauque P; Guibert J; Jouannet P; Patrat C
    Fertil Steril; 2008 Apr; 89(4):991.e1-4. PubMed ID: 17603057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study.
    Weiss A; Neril R; Geslevich J; Lavee M; Beck-Fruchter R; Golan J; Shalev E
    Fertil Steril; 2014 Aug; 102(2):419-23. PubMed ID: 24880653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
    Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
    Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification.
    Shalom-Paz E; Almog B; Shehata F; Huang J; Holzer H; Chian RC; Son WY; Tan SL
    Reprod Biomed Online; 2010 Oct; 21(4):566-71. PubMed ID: 20822957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadvertent recombinant human follicle stimulating hormone bolus instead of human chorionic gonadotrophin leads to the retrieval of competent oocytes in IVF program.
    Bianchi V; Dal Prato L; Maccolini A; Mazzone S; Borini A
    Fertil Steril; 2009 Nov; 92(5):1747.e1-3. PubMed ID: 19732874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: A novel strategy of fertility preservation for breast cancer patients.
    Huang JY; Chian RC; Gilbert L; Fleiszer D; Holzer H; Dermitas E; Elizur SE; Gidoni Y; Levin D; Son WY; Tan SL
    Am J Surg; 2010 Jul; 200(1):177-83. PubMed ID: 20637351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment.
    Chian RC; Buckett WM; Abdul Jalil AK; Son WY; Sylvestre C; Rao D; Tan SL
    Fertil Steril; 2004 Dec; 82(6):1675-8. PubMed ID: 15589878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval.
    Raziel A; Schachter M; Strassburger D; Kasterstein E; Ron-El R; Friedler S
    Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
    Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
    Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
    Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Techniques for fertility preservation in patients with breast cancer.
    Dunn L; Fox KR
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):68-73. PubMed ID: 19125006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.